These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 29464446)

  • 1. Supportive therapy in gastroenteropancreatic neuroendocrine tumors: Often forgotten but important.
    Jin XF; Spampatti MP; Spitzweg C; Auernhammer CJ
    Rev Endocr Metab Disord; 2018 Jun; 19(2):145-158. PubMed ID: 29464446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tale of two tumors: treating pancreatic and extrapancreatic neuroendocrine tumors.
    Halperin DM; Kulke MH; Yao JC
    Annu Rev Med; 2015; 66():1-16. PubMed ID: 25341008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of gastroentero-pancreatic neuroendocrine tumors (GEP-NETs).
    Desai KK; Khan MS; Toumpanakis C; Caplin ME
    Minerva Gastroenterol Dietol; 2009 Dec; 55(4):425-43. PubMed ID: 19942827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroendocrine tumors of the gastrointestinal tract].
    Arnold C
    Praxis (Bern 1994); 2007 Jan; 96(1-2):19-28. PubMed ID: 17256557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes.
    Hofland J; Falconi M; Christ E; Castaño JP; Faggiano A; Lamarca A; Perren A; Petrucci S; Prasad V; Ruszniewski P; Thirlwell C; Vullierme MP; Welin S; Bartsch DK
    J Neuroendocrinol; 2023 Aug; 35(8):e13318. PubMed ID: 37578384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Well-differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEPNETs): A Review.
    Pasricha G; Padhi P; Daboul N; Monga DK
    Clin Ther; 2017 Nov; 39(11):2146-2157. PubMed ID: 29173655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroenteropancreatic Neuroendocrine Tumors.
    Cives M; Strosberg JR
    CA Cancer J Clin; 2018 Nov; 68(6):471-487. PubMed ID: 30295930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors in Korea: Literature Review and Expert Opinion.
    Yoo C; Oh CR; Kim ST; Bae WK; Choi HJ; Oh DY; Lee MA; Ryoo BY
    Cancer Res Treat; 2021 Apr; 53(2):291-300. PubMed ID: 33421978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update in the management of gastroenteropancreatic neuroendocrine tumors.
    Sedlack AJH; Varghese DG; Naimian A; Yazdian Anari P; Bodei L; Hallet J; Riechelmann RP; Halfdanarson T; Capdevilla J; Del Rivero J
    Cancer; 2024 Sep; 130(18):3090-3105. PubMed ID: 39012928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroendocrine tumors of the digestive system].
    Prónai L; Rácz K; Tulassay Z
    Orv Hetil; 2002 May; 143(19 Suppl):1081-6. PubMed ID: 12063866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors.
    Phan AT; Kunz PL; Reidy-Lagunes DL
    Clin Adv Hematol Oncol; 2015 May; 13(5 Suppl 5):1-18; quiz 1 p following 18. PubMed ID: 26430956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Gastroenteropancreatic Neuroendocrine Tumors.
    Perez K; Chan J
    Surg Pathol Clin; 2019 Dec; 12(4):1045-1053. PubMed ID: 31672293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors.
    Jiménez-Fonseca P; Carmona-Bayonas A; Martín-Pérez E; Crespo G; Serrano R; Llanos M; Villabona C; García-Carbonero R; Aller J; Capdevila J; Grande E;
    Cancer Metastasis Rev; 2015 Sep; 34(3):381-400. PubMed ID: 26245646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostics and treatment in functional pancreatic neuroendocrine tumours].
    Müssig K; Dudziak K; Horger M; Anlauf M; Goretzki PE
    Dtsch Med Wochenschr; 2011 Jun; 136(24):1319-30. PubMed ID: 21656454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging role of targeted therapies for advanced well-differentiated gastroenteropancreatic neuroendocrine tumors.
    Cloyd JM; Konda B; Shah MH; Pawlik TM
    Expert Rev Clin Pharmacol; 2019 Feb; 12(2):101-108. PubMed ID: 30582383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical management of secretory syndromes related to gastroenteropancreatic neuroendocrine tumours.
    Dimitriadis GK; Weickert MO; Randeva HS; Kaltsas G; Grossman A
    Endocr Relat Cancer; 2016 Sep; 23(9):R423-36. PubMed ID: 27461388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New and emerging systemic therapy options for well-differentiated gastroenteropancreatic neuroendocrine tumors.
    Scoville SD; Cloyd JM; Pawlik TM
    Expert Opin Pharmacother; 2020 Feb; 21(2):183-191. PubMed ID: 31760823
    [No Abstract]   [Full Text] [Related]  

  • 18. [Endocrine-active gastrointestinal tumors: are there any new therapeutic possibilities?].
    Marbet UA; Kraenzlin M; Gyr K; Stalder GA
    Dtsch Med Wochenschr; 1986 Jul; 111(28-29):1120-3. PubMed ID: 2426077
    [No Abstract]   [Full Text] [Related]  

  • 19. The State of Peptide Receptor Radionuclide Therapy and Its Sequencing among Current Therapeutic Options for Gastroenteropancreatic Neuroendocrine Tumors.
    Raymond LM; Korzun T; Kardosh A; Kolbeck KJ; Pommier R; Mittra ES
    Neuroendocrinology; 2021; 111(11):1086-1098. PubMed ID: 33744879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of Interventional Radiology in the management of Gastro-Entero-Pancreatic Neuroendocrine Tumours (GEP-NETs).
    Orgera G; Krokidis M; Cappucci M; Gourtsoyianni S; Tipaldi MA; Hatzidakis A; Rebonato A; Rossi M
    Cardiovasc Intervent Radiol; 2015 Feb; 38(1):13-24. PubMed ID: 25366087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.